Other key activating receptors, such as natural cytotoxicity receptors or NCRs (NKp30, NKp44, and NKp46) are downregulated in acute myeloid leukemia (AML) correlating with poor prognosis and lower survival rates [37]. Here, NCR2 is linked to acute myeloid leukemia.